Individual Effector/Regulator T Cell Ratios Impact Bone Regeneration.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 10 05 2019
accepted: 02 08 2019
entrez: 3 9 2019
pubmed: 3 9 2019
medline: 7 10 2020
Statut: epublish

Résumé

There is increasing evidence that T lymphocytes play a key role in controlling endogenous regeneration. Regeneration appears to be impaired in case of local accumulation of CD8+ effector T cells (T

Identifiants

pubmed: 31475013
doi: 10.3389/fimmu.2019.01954
pmc: PMC6706871
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1954

Références

J Orthop Sci. 2004;9(1):22-8
pubmed: 14767701
J Exp Med. 2004 May 17;199(10):1401-8
pubmed: 15148338
Injury. 2005 Dec;36(12):1392-404
pubmed: 16102764
Injury. 2007 Mar;38(3):365-70
pubmed: 17241634
J Immunol. 2007 Jun 1;178(11):6725-9
pubmed: 17513718
Arthritis Rheum. 2007 Dec;56(12):4104-12
pubmed: 18050211
Immunity. 2008 Jul 18;29(1):44-56
pubmed: 18585065
Blood. 2008 Sep 15;112(6):2340-52
pubmed: 18617638
J Bone Miner Res. 2009 Feb;24(2):251-64
pubmed: 18847332
Eur J Immunol. 2008 Dec;38(12):3274-81
pubmed: 19039774
Cancer Res. 2009 Jan 15;69(2):599-608
pubmed: 19147574
Blood. 2009 Apr 30;113(18):4240-9
pubmed: 19171879
J Orthop Res. 2009 Sep;27(9):1147-51
pubmed: 19382195
Nat Immunol. 2009 Sep;10(9):1000-7
pubmed: 19633673
J Immunol. 2010 Jun 15;184(12):7238-46
pubmed: 20483756
Arthritis Rheum. 2010 Aug;62(8):2328-38
pubmed: 20506516
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Science. 2010 Sep 24;329(5999):1667-71
pubmed: 20929851
Injury. 2011 Dec;42(12):1435-42
pubmed: 21665205
Cell Tissue Res. 2012 Mar;347(3):567-73
pubmed: 21789579
Rheumatol Int. 2012 Sep;32(9):2731-6
pubmed: 21809006
Nat Med. 2011 Nov 20;17(12):1594-601
pubmed: 22101767
J Tissue Eng Regen Med. 2014 Feb;8(2):120-30
pubmed: 22495762
PLoS One. 2012;7(9):e44552
pubmed: 22970248
Sci Transl Med. 2013 Mar 20;5(177):177ra36
pubmed: 23515078
J Surg Res. 1990 May;48(5):460-3
pubmed: 2352421
Epigenetics. 2013 Nov;8(11):1226-35
pubmed: 24071829
Expert Opin Biol Ther. 2014 Feb;14(2):247-59
pubmed: 24397854
Bone. 2014 Jul;64:155-65
pubmed: 24721700
Ann Surg. 1989 Apr;209(4):479-83
pubmed: 2522759
Nat Rev Rheumatol. 2015 Jan;11(1):45-54
pubmed: 25266456
Front Pharmacol. 2015 Sep 02;6:184
pubmed: 26388774
Bone. 2018 Jan;106:78-89
pubmed: 26529389
J Exp Orthop. 2015 Dec;2(1):1
pubmed: 26914869
Lab Anim. 2016 Dec;50(6):433-441
pubmed: 27909193
Front Immunol. 2017 May 24;8:562
pubmed: 28596766
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
Curr Osteoporos Rep. 2018 Apr;16(2):155-168
pubmed: 29536393
FASEB J. 2018 Jun 4;:fj201701408R
pubmed: 29863913
PLoS One. 2018 Jun 7;13(6):e0198510
pubmed: 29879182
Front Immunol. 2018 May 28;9:1069
pubmed: 29892281
Sci Transl Med. 2018 Aug 1;10(452):null
pubmed: 30068569
Front Immunol. 2019 Apr 12;10:797
pubmed: 31031773
Yonsei Med J. 1995 May;36(2):130-6
pubmed: 7618360
J Trauma. 1997 May;42(5):895-903; discussion 903-4
pubmed: 9191672
J Bone Miner Res. 1998 Nov;13(11):1648-56
pubmed: 9797472

Auteurs

Claudia Schlundt (C)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Simon Reinke (S)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Sven Geissler (S)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Christian H Bucher (CH)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Carolin Giannini (C)

Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Sven Märdian (S)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Michael Dahne (M)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Christian Kleber (C)

University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, Dresden, Germany.

Björn Samans (B)

Epiontis GmbH, Precision for Medicine Group, Berlin, Germany.

Udo Baron (U)

Epiontis GmbH, Precision for Medicine Group, Berlin, Germany.

Georg N Duda (GN)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.

Hans-Dieter Volk (HD)

Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.

Katharina Schmidt-Bleek (K)

Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH